Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Adam Alexander, OD

Advertisement

Articles by Adam Alexander, OD

Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo

AOA 2024: Early adoption and utilization of perfluorohexceloctane (Miebo) for dry eye disease

ByJordana Joy, Associate Editor,Adam Alexander, OD
June 13th 2024

According to Adam Alexander, OD, Miebo can make headway in establishing a need for precision medication when it comes to dry eye treatment.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Optometry Times - Clinical News & Expert Optometrist Insights

    1

    Neurotrophic keratitis in focus: Diagnosis, treatment, and practice pearls

    2

    Adapting Jupiter Trial Approaches for Treating Low Baseline Pressure Glaucoma

    3

    Key Takeaways in Glaucoma Management From Real-World Clinical Scenarios

    4

    Optimizing Moderate-to-Severe Glaucoma Through Medication Switching and Adherence Strategies

    5

    Managing Cataract and Glaucoma Patients by Combining MIGS and Sustained Drug Delivery to Improve Quality of Life

    • Advertise
    • About Us
    • Editorial
    • Contact Us
    • Job Board
    • Terms & Conditions
    • Privacy
    • Do not sell my Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Ophthalmology Times
    • Modern Retina
    • Optometry Times
    • Ophthalmology Times Europe
    Collaborative Care Symposium
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us